연구업적

연구

연구
연구업적

최근 5년 연구업적 현황

연도		2024년	2023년	2022년	2021년	2020년
SCI 논문 발표편수	책임	179편	173편	163편	184편	135편
SCI 논문 발표편수	공동	147편	120편	115편	136편	168편
합계		326편	293편	278편	320편	303편

1557. Codon-optimized human sodium iodide symporter (opt-hNIS) as a sensitive reporter and efficient therapeutic gene

Kim YH, Youn H*, Na J, Hong K-J, Kang KW, Lee DS, Chung JK

Theranostics 2015 Jan 1; 5(1)86-96. Link

1556. Targeting BRG1 chromatin remodeler via its bromodomain for enhanced tumor cell radiosensitivity in vitro and in vivo.

Kwon SJ1, Lee SK1, Na J2, Lee SA1, Lee HS1, Park JH1, Chung JK3, Youn H4, Kwon J5.

Mol Cancer Ther. 2014 Dec 12. pii: molcanther.0372.2014 14(2)1-11 Link

1555. Lesionalized therapy beyond personalized therapy in cancer management.

Chung JK, Kim MJ, Youn H*

Journal of Korean Medical Sciences 2014 Oct;29 (10):1331-2 Link

1554. In vivo bioluminescence imaging of transplanted mesenchymal stem cells as a potential source for pancreatic regeneration.

Lee S, Youn H*, Chung TM, Hwang DW, Oh SW, Lee DS

Mol Imaging. 2014 Sep 1;13(0)1-12 Link

1553. Establishment of cell lines from both myeloma bone marrow and plasmacytoma: SNU_MM1393_BM and SNU_MM1393_SC from a single patient.

Koh Y, Jung WJ, Ahn KS, Yoon SS

Biomed Res Int. 2014;2014:510408. Link

1552. NT5C3 polymorphisms and outcome of first induction chemotherapy in acute myeloid leukemia

Cheong HS, Koh Y, Ahn KS, Lee C, Shin HD, Yoon SS

Pharmacogenet Genomics. 2014 Sep;24(9):436-41. Link

1551. Allogeneic stem cell transplantation in patients with de novo diffuse large B-cell lymphoma who experienced relapse or progression after autologous stem cell transplantation: a Korea-Japan collaborative study.

Kim JW1, Kim SW, Tada K, Fukuda T, Lee JH, Lee JJ, Kwon JH, Bang SM, Kim I, Yoon SS, Lee JS, Park S.

Ann Hematol. 2014 Aug;93(8):1345-51. doi: 10.1007/s00277-014-2045-9. Epub 2014 Mar 16. Link

1550. Establishment and characterization of bortezomib-resistant U266 cell line: constitutive activation of NF-κB-mediated cell signals and/or alterations of ubiquitylation-related genes reduce bortezomib-induced apoptosis.

Park J, Bae EK, Lee C, Choi JH, Jung WJ, Ahn KS, Yoon SS

BMB Rep. 2014 May;47(5):274-9. Link

1549. Adjuvant single-fraction radiotherapy is safe and effective for intractable keloids.

.Song C1, Wu HG2, Chang H3, Kim IH4, Ha SW4.

J Radiat Res 2014, 55(5), 912-916 Link

1548. Dose-volumetric parameters for predicting hypothyroidism after radiotherapy for head and neck cancer.

Kim MY, Yu T, Wu HG.

Jpn J Clin Oncol 2014, 44(4), 331-337 Link